UVC Partners

Unternehmertum Venture Capital Partners (UVC Partners) is a Munich- and Berlin-based early-stage venture capital firm that invests in European technology startups. UVC Partners focuses on investments in the areas of industrial technologies, enterprise software and mobility. The fund typically invests at the Seed and Series A stage between €0.5-4m initially and up to €15m in total per company.

Amanda-Stella Birkenholz

Investment Manager

Alexander Huber

CFO

Lisa Liu

Investment Manager

Daniel Reese

Investment Manager

Oliver Schoppe

Investment Manager

Anne von Wolff

Investment Associate

Past deals in Germany

Arzneimittelwerk Warngau

Series C in 2016
Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.

Arzneimittelwerk Warngau

Series B in 2015
Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.